Tamarack Advisers’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-15,000
Closed -$1.98M 54
2021
Q2
$1.98M Sell
15,000
-135,000
-90% -$17.7M 0.56% 33
2021
Q1
$19.3M Sell
150,000
-15,000
-9% -$1.85M 3.95% 8
2020
Q4
$19.8M Buy
165,000
+65,000
+65% +$7.92M 4.13% 9
2020
Q3
$11.4M Sell
100,000
-175,000
-64% -$20.7M 3.53% 12
2020
Q2
$31.3M Sell
275,000
-42,000
-13% -$4.45M 8.73% 2
2020
Q1
$25.5M Buy
317,000
+72,000
+29% +$7.45M 9.64% 1
2019
Q4
$25.7M Buy
245,000
+70,000
+40% +$7.3M 5.88% 6
2019
Q3
$18.7M Sell
175,000
-13,900
-7% -$1.43M 4.88% 9
2019
Q2
$19.4M Buy
+188,900
New +$18.2M 5.89% 8
2018
Q1
Sell
-50,000
Closed -$4.92M 29
2017
Q4
$4.92M Buy
+50,000
New +$4.74M 2.69% 12
2016
Q4
Sell
-8,557
Closed -$716K 30
2016
Q3
$716K Sell
8,557
-174,900
-95% -$14.7M 0.23% 31
2016
Q2
$14.9M Sell
183,457
-181,543
-50% -$13.8M 5.73% 5
2016
Q1
$26.1M Sell
365,000
-285,000
-44% -$19.1M 9.13% 2
2015
Q4
$46.2M Buy
+650,000
New +$43.7M 6.09% 4

Other funds holding DGX

Tamarack Advisers's DGX Position: Q3 2021 in Review

Tamarack Advisers sold out of Quest Diagnostics (DGX) in Q3 2021, closing a stake of 15,000 shares — an estimated $1.98M sold.

Tamarack Advisers first reported a position in DGX in Q4 2015 and held it in 14 quarters. The position peaked at $46.2M in Q4 2015. 838 funds tracked by Wall St. Rank hold DGX as of Q3 2021.

  • Tamarack Advisers reported no remaining Quest Diagnostics position as of Q3 2021 after selling out during the quarter.
  • Tamarack Advisers sold 15,000 Quest Diagnostics shares in Q3 2021, an estimated $1.98M.
  • Tamarack Advisers first reported a position in Quest Diagnostics in Q4 2015 and held it in 14 quarters.
  • Tamarack Advisers's Quest Diagnostics position peaked at $46.2M in Q4 2015.
  • 838 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2021.

Based on Tamarack Advisers's 13F filing for Q3 2021, filed 12 Nov 2021.